Insights Into Imaging

Journal Title：Insights Into Imaging

Insights into Imaging (I³) is a peer-reviewed open access journal published under the brand SpringerOpen. All content published in the journal is freely available online to anyone, anywhere!

I³ continuously updates scientific knowledge and progress in best-practice standards in radiology through the publication of original articles and state-of-the-art reviews and opinions, along with recommendations and statements from the leading radiological societies in Europe.

Founded by the European Society of Radiology (ESR), I³ creates a platform for educational material, guidelines and recommendations, and a forum for topics of controversy.

A balanced combination of review articles, original papers, short communications from European radiological congresses and information on society matters makes I³ an indispensable source for current information in this field.

I³ is owned by the ESR, however authors retain copyright to their article according to the Creative Commons Attribution License (see Copyright and License Agreement). All articles can be read, redistributed and reused for free, as long as the author of the original work is cited properly.

The open access fees (article-processing charges) for this journal are kindly sponsored by ESR for all Members.

The journal went open access in 2012, which means that all articles published since then are freely available online.

Insights into Imaging (I³) 是 SpringerOpen 品牌下出版的同行评审开放获取期刊。期刊上发表的所有内容均可在线免费供任何人、任何地方使用！

I³ 通过发表原创文章和最新评论和观点以及欧洲领先放射学会的建议和声明，不断更新科学知识和放射学最佳实践标准的进展。

I³ 由欧洲放射学会 (ESR) 创立，为教育材料、指南和建议以及争议主题论坛创建了一个平台。

评论文章、原创论文、欧洲放射学大会的简短通讯和社会事务信息的平衡组合使 I³ 成为该领域最新信息的不可或缺的来源。

I³ 归 ESR 所有，但作者根据知识共享署名许可保留其文章的版权（请参阅版权和许可协议）。所有文章均可免费阅读、重新分发和重复使用，只要正确引用原作者即可。

本期刊的开放获取费用（文章处理费）由 ESR 为所有会员提供赞助。

本期刊于 2012 年开放获取，这意味着自那时起发表的所有文章均可在线免费获取。

Insights Into Imaging创刊于2010年，由Springer Berlin Heidelberg出版商出版，收稿方向涵盖Medicine - Radiology, Nuclear Medicine and Imaging全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 13 Weeks ，影响因子指数4.1，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。